Cargando…
CHALLENGES RELATED TO DATA SOURCES FOR RWE IN AGING RESEARCH
Numerous challenges remain in research to generate RWE for FDA approvals and other health care decision-makers or stakeholders. This is particularly true for research to evaluate the effectiveness of pharmaceutical care and patient outcomes in older populations. For example, data sources available f...
Autor principal: | Lu, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766004/ http://dx.doi.org/10.1093/geroni/igac059.771 |
Ejemplares similares
-
USE OF RWD TO GENERATE RWE IN THE ALZHEIMER'S DISEASE SETTING: CHALLENGES AND FUTURE DIRECTIONS
por: DiBello, Julia
Publicado: (2022) -
Real world evidence (RWE) - Are we (RWE) ready?
por: Suvarna, Viraj Ramesh
Publicado: (2018) -
Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
por: Maison, Patrick, et al.
Publicado: (2022) -
Using RWE research to extend clinical trials in diabetes: An example with implications for the future
por: Seeger, John D., et al.
Publicado: (2020) -
Paving the way for patient centricity in real-world evidence (RWE): Qualitative interviews to identify considerations for wider implementation of patient-reported outcomes in RWE generation
por: Maruszczyk, Konrad, et al.
Publicado: (2023)